This is a preview of subscription content, log in via an institution to check access.
Notes
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Reference
Hillhouse E, et al. The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review. Advances in Therapy : 15 Nov 2021. Available from: URL: https://doi.org/10.1007/s12325-021-01951-z
Rights and permissions
About this article
Cite this article
Originator-to-biosimilar non-medical switch may not yield such great cost savings. PharmacoEcon Outcomes News 892, 17 (2021). https://doi.org/10.1007/s40274-021-08212-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08212-z